Former Officer Acquires $53,921 Worth of Owens & Minor Shares in Recent Insider Move
October 17, 2024

☀️Trending News
Owens & Minor ($NYSE:OMI), Inc. is a healthcare distribution company that provides services and solutions to hospitals, healthcare systems, and other healthcare providers. Owens & Minor operates through two segments: Global Solutions and Global Products. The recent insider activity at Owens & Minor has put the company under close scrutiny. This significant purchase by an insider has raised questions and piqued the interest of investors and analysts alike. The purchase by Bruni Alexander J signals confidence in the company’s future prospects. Insiders are individuals with access to privileged information about the company, and their actions can be seen as a reflection of their belief in the company’s potential. When insiders buy shares, it is often perceived as a positive indication of the company’s performance and outlook.
However, the recent insider purchase could be an indicator that the company is poised for growth and could see an upward trend in its stock price. However, with the rollout of vaccines and easing of restrictions, the demand for healthcare products and services is expected to rebound. This could bode well for Owens & Minor and its shareholders. With the healthcare industry poised for recovery, the company’s performance and stock price may see an upward trajectory. This insider move could be seen as a positive signal for investors, but as with any investment decision, thorough research and analysis are crucial.
Market Price
This move has sparked interest and speculation among investors and analysts. On Wednesday, the day of the insider transaction, OWENS & MINOR stock opened at $14.09 and closed at $14.03. This represented a slight increase of 0.29% from the previous closing price of $13.99. While the increase was minimal, it is worth noting that the stock has been on a downward trend in recent months. The acquisition of shares by a former officer is often seen as a positive sign, as insiders typically have more knowledge and insight into the company’s operations and future prospects. This move could be interpreted as a show of confidence in OWENS & MINOR’s potential for growth and profitability.
However, any insider transaction, regardless of the amount, can provide valuable information to investors and potentially affect stock prices. This insider transaction could be seen as an attempt to take advantage of the low stock price and potentially capitalize on future gains. Overall, while this insider move may not have a significant impact on OWENS & MINOR’s stock price in the short term, it could be seen as a positive indicator for the company’s future prospects. Investors will continue to closely monitor any further insider transactions and company developments to make informed decisions about their investments. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for OMI. More…
| Total Revenues | Net Income | Net Margin |
| 10.33k | -41.3 | 1.0% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for OMI. More…
| Operations | Investing | Financing |
| 740.71 | -137.25 | -417.33 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for OMI. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 5.09k | 4.17k | 11.59 |
Key Ratios Snapshot
Some of the financial key ratios for OMI are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 6.8% | 8.0% | 1.0% |
| FCF Margin | ROE | ROA |
| 5.2% | 7.3% | 1.3% |
Analysis
In my analysis of OWENS & MINOR, I found that this company falls under the ‘rhino’ category according to our Star Chart. This means that it has achieved moderate revenue or earnings growth. This type of company may be attractive to investors who are looking for steady and stable growth without too much risk involved. Digging deeper into the financials, I observed that OWENS & MINOR is strong in terms of growth and profitability, but weak in its assets and dividend payments. This suggests that the company may have potential for future growth, but may also need to improve its asset management and dividend policies. However, one key aspect that stood out to me was OWENS & MINOR’s high health score of 7/10. This indicates that the company has a strong cash flow and manageable debt levels, making it well-equipped to weather any potential financial crises. This could be reassuring for investors who prioritize stability and long-term sustainability in their investment decisions. Overall, based on my analysis, OWENS & MINOR may be of interest to investors who are seeking moderate growth potential with a relatively low level of risk. It also has strong financial health, making it a potentially attractive option for those looking for a stable and reliable investment. More…

Peers
Owens & Minor Inc is in the business of distributing medical supplies and providing related services to healthcare providers. The company operates in North America and Europe. Its competitors include Orthofix Medical Inc, Medirect Latino Inc, PT Millennium Pharmacon International Tbk.
– Orthofix Medical Inc ($NASDAQ:OFIX)
Orthofix Medical Inc is a medical device company that provides orthopedic solutions to patients worldwide. The company has a market cap of 297.51M as of 2022 and a Return on Equity of -4.8%. The company’s products are used in the treatment of various conditions, including osteoarthritis, degenerative disc disease, scoliosis, and deformities. The company’s products are sold through a network of distributors and retailers.
– Medirect Latino Inc ($OTCPK:MLTO)
PT Millennium Pharmacon International Tbk is a leading pharmaceutical company in Indonesia with a market cap of 156.7B as of 2022. The company has a strong focus on research and development, and has a strong portfolio of products. The company has a Return on Equity of 17.77%.
Summary
Recent insider movements in Owens & Minor, Inc. have caught the attention of investors. Former Officer Bruni Alexander J acquired the company’s shares for $53921.0 on September 20th, 2024. This could indicate that the insider has faith in the company’s future and believes the stock is undervalued. As such, investors may want to closely monitor the company’s performance and financials in the coming months. Additionally, this insider activity could potentially signal a positive outlook for the company and may lead to increased investor confidence.
However, it is important to conduct further analysis and research before making any investment decisions.
Recent Posts









